{"retracted":false,"update":{"timestamp":1477958400000,"doi":"10.1016/j.lungcan.2016.06.002","type":"erratum"},"doi":"10.1016/j.lungcan.2006.06.006","journal":"Lung Cancer","publisher":"Elsevier BV","title":"Corrigendum to “In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2” [Lung Cancer 53 (3) (September 2006) 273–284]"}
